3.6 C
Glasgow
Friday, January 30, 2026
spot_img

More News

Why tumours become aggressive and genetically unstable

Jim Cornall -
A new study shows that cancer damages its own DNA by pushing key genes to work too hard. Cancer cells...

DIA launches platform to boost drug development

Jim Cornall -
The Drug Information Association (DIA) has launched DIA ASCENT, a new global platform designed to support early-stage biotechnology drug...

Nanoscope boosts retina gene therapy in Japan

Jim Cornall -
Nanoscope Therapeutics, Inc., a biotechnology company developing disease-agnostic therapies for vision loss caused by retinal degeneration, has announced that...

Ouro Medicines receives Fast Track Designation for gamgertamig

Jim Cornall -
Ouro Medicines, which is developing immune reset therapeutics for people living with chronic, immune-mediated diseases, has announced that gamgertamig,...

Infinitopes raises more funds for precision cancer vaccine

Jim Cornall -
Infinitopes, a clinical-stage cancer vaccine biotechnology company, has completed the second close of its seed financing round, securing an...

Women in Life Science Denmark expands with launch of WiLD Finland

Jim Cornall -
Women in Life Science Denmark (WiLD), the Nordic non-profit network dedicated to advancing women into senior leadership positions in...

Lilly platinum-resistant ovarian cancer drug receives U.S. FDA’s Breakthrough Therapy designation

Jim Cornall -
Eli Lilly and Company has announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation...

How cancer cells protect themselves from the immune system

Jim Cornall -
An international research team has succeeded in deciphering a key mechanism that controls the growth of pancreatic cancers. The...

Zaire ebolavirus vaccine development advancing

Jim Cornall -
SK bioscience is advancing the development of a Zaire ebolavirus vaccine under a new collaboration supported by the Coalition...

Base to Base biotech podcast 43: Natural killer cell therapy and attacking tumours

Jim Cornall -
This week, we have a conversation with Lisa Guerrettaz, executive director, Pharmacology and Translational Science at Artiva Biotherapeutics; and...

Brainomix e-Lung AI imaging technology selected in Boehringer Ingelheim pulmonary fibrosis trial

Jim Cornall -
Brainomix has announced it was selected by Boehringer Ingelheim to provide objective, quantitative HRCT imaging biomarkers as a co-primary...

Scientists uncover hidden cells fuelling brain cancer — and a drug that could stop them

Jim Cornall -
A team of Canadian scientists has uncovered a new way to slow the growth of glioblastoma, the most aggressive...

Wiskott-Aldrich syndrome treatment approved

Jim Cornall -
With the decision by the U.S. Food and Drug Administration and the European Commission to grant market authorization for...

Positive phase 3 results from insomnia trial

Jim Cornall -
Nxera Pharma Co., Ltd. has announced positive top-line results from a phase 3 study in South Korea evaluating daridorexant...

AbbVie announces topline results for phase 3 lymphoma trial

Jim Cornall -
AbbVie has announced topline results from its phase 3 EPCORE DLBCL-1 trial evaluating epcoritamab, a T-cell engaging bispecific antibody...

Novo Nordisk Foundation grants $860m to boost innovation in Denmark and Europe

Jim Cornall -
The Novo Nordisk Foundation has allocated up to DKK5.5bn ($860m) to BioInnovation Institute (BII), a leading institute for life...

University of Pennsylvania, BioNTech, and OUP launch $50m life sciences fund

Jim Cornall -
The University of Pennsylvania (Penn), BioNTech SE, and OUP (Osage University Partners) have launched the $50m Penn-BioNTech Innovative Therapeutics...

COPD focussed AirNexis Therapeutics launches

Jim Cornall -
AirNexis Therapeutics, a clinical stage biotech company developing therapeutics for pulmonary diseases, has announced the close of a $200m...

Agentic AI framework launched to improve life sciences decision-making

Jim Cornall -
Lynx Analytics has announced Lumen, a specialised Agentic AI framework designed to help pharmaceutical and biotech organisations generate strategic,...

First-in-human drug trial lowers high blood fats

Jim Cornall -
When we eat, our bodies convert extra calories, especially from carbs, sugar, fats, and alcohol, into triglycerides. Triglycerides are a...

New way to disarm antibiotic-resistant bacteria and restore healing in chronic wounds

Jim Cornall -
An international team of scientists, led by Nanyang Technological University, Singapore (NTU Singapore), has discovered a new way that...

Deeptech Digest is your guide to what's new in at the cutting edge of science technology. A bit of artificial intelligence, some biotech, and all the news and latests developments in the field. If it's deeptech, it's in Deeptech Digest!

Contact us: jim@deeptechdigest.com

© 2023 Ayr Coastal Media